Compare JZXN & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JZXN | BBLG |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | China | United States |
| Employees | N/A | 2 |
| Industry | Retail-Auto Dealers and Gas Stations | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.5M |
| IPO Year | 2020 | N/A |
| Metric | JZXN | BBLG |
|---|---|---|
| Price | $1.52 | $1.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.7M | 52.2K |
| Earning Date | 02-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $1.05 |
| 52 Week High | $8.50 | $4.13 |
| Indicator | JZXN | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 45.38 |
| Support Level | $0.96 | $1.24 |
| Resistance Level | $1.89 | $1.38 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 22.96 | 21.44 |
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It is into trade business with a focus on sales of new energy batteries including design, commissioned processing, transportation and packaging, sales of electrical equipment, mobile phone accessories and other products. Its revenues consist of two reportable operating segments: (i) Sales of new energy batteries, including production, transportation, and packaging, in the mainland Pearl River Delta region; and(ii) Sales and production of electric vehicles in Southeast Asia, including two-wheelers, three-wheeled electric scooters, and slow-speed vehicles.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.